Progyny Financials - Benzinga

Progyny Inc

PGNYNASDAQ

Trade with Public

Trade with Public

$25.64

0.050.2%

Dern. MÀJ: Sep 1, 12:18 PM

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Options Rapport sur les stocks

Progyny Financials

Progyny (PGNY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Progyny Sees Q3 GAAP EPS $0.30-$0.33 vs $0.34 Est

Progyny (NASDAQ:PGNY) is looking for Q3 GAAP EPS of $0.30-$0.33 vs $0.34 analyst estimate..

Benzinga Newsdesk

PRO
Progyny Sees Q3 Adj EPS $0.50-$0.52 vs $0.33 Est; Sees Sales $335.000M-$345.000M vs $350.185M Est

Progyny (NASDAQ:PGNY) is looking for Q3 Adj EPS of $0.50-$0.52 vs $0.33 analyst estimate. sees sales of $335.000 million-$345.000 million vs $350.185 million analyst estimate.

Benzinga Newsdesk

PRO
Progyny Narrows FY2026 GAAP EPS Guidance from $1.23-$1.34 to $1.26-$1.32 vs $1.29 Est

Progyny (NASDAQ:PGNY) narrows FY2026 GAAP EPS guidance from $1.23-$1.34 to $1.26-$1.32 vs $1.29 analyst estimate..

Benzinga Newsdesk

PRO
Progyny Raises FY2026 Adj EPS Guidance from $1.98-$2.09 to $2.04-$2.10 vs $1.29 Est; Lowers FY2026 Sales Guidance from $1.365B-$1.405B to $1.360B-$1.385B vs $1.384B Est

Progyny (NASDAQ:PGNY) raises FY2026 Adj EPS guidance from $1.98-$2.09 to $2.04-$2.10 vs $1.29 analyst estimate. Lowers FY2026 sales outlook from $1.365 billion-$1.405 billion to $1.360 billion-$1.385 billion vs $1.384

Benzinga Newsdesk

PRO
Progyny Q2 Adj. EPS $0.55 Beats $0.34 Estimate, Sales $350.511M Beat $348.682M Estimate

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.34 by 61.76 percent. This is a 14.58 percent increase over earnings of $0.48 per share from the same

Benzinga Newsdesk

PRO
Progyny Sees Q2 GAAP EPS $0.31-$0.35 vs $0.30 Est

Progyny (NASDAQ:PGNY) is looking for Q2 GAAP EPS of $0.31-$0.35 vs $0.30 analyst estimate..

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved